Breaking News Instant updates and real-time market news.

14:15
01/15/20
01/15
14:15
01/15/20
14:15

Fed's Beige Book: overall the economy expanded "modestly"

Fed's Beige Book: overall the economy expanded "modestly" in the last six weeks of 2019. A couple of Districts, Dallas and Richmond, noted above-average growth, while Philly, St Louis, and KC reported below-average results. Employment was "steady" or rose "modestly" and labor markets remained "tight." Most Districts reported labor shortages Consumer spending grew at a "modest to moderate" pace. A number of Districts reported job cuts or reduced hiring among manufacturers, and some in transportation and energy sectors. Wage growth remained "modest" or "moderate."Holiday sales were reportedly "solid" with a note toward the growing importance of on-line shopping. Vehicle sales grew "moderately." Manufacturing was essentially "flat," as was the case in the prior report. Business nonfinancial services activity was mixed but generally grew "modestly." Home sales trends were varied. Prices continued to rise at a "modest" pace, as did input costs. A "few" Districts said some businesses were passing along tariff costs to consumers, mostly in retail, but also construction. Some Districts also noted prices were expected to continue to rise in the months ahead. The report was prepared by the NY Fed using data on or before January 6.

TODAY'S FREE FLY STORIES

Downgrade
Intel shares have 'chicken or egg' problem, says Northland » 07:23
01/27/20
01/27
07:23
01/27/20
07:23
INTC

Intel

$68.47 /

+5.15 (+8.13%)

Northland analyst Gus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
S&P Global upgraded to Outperform from Market Perform at BMO Capital » 07:22
01/27/20
01/27
07:22
01/27/20
07:22
SPGI

S&P Global

$294.82 /

-2.51 (-0.84%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Chewy upgraded to Outperform at Wedbush on online pet industry sales growth » 07:21
01/27/20
01/27
07:21
01/27/20
07:21
CHWY

Chewy

$28.48 /

+0.41 (+1.46%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
IHS Markit downgraded to Market Perform from Outperform at BMO Capital » 07:20
01/27/20
01/27
07:20
01/27/20
07:20
INFO

IHS Markit

$79.89 /

-0.7 (-0.87%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Intelligent Systems initiated with a Buy at BTIG » 07:19
01/27/20
01/27
07:19
01/27/20
07:19
INS

Intelligent Systems

$40.39 /

+0.35 (+0.87%)

, AAPL

Apple

$318.25 /

-1.02 (-0.32%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Halozyme price target raised to $35 from $27 at Cantor Fitzgerald » 07:18
01/27/20
01/27
07:18
01/27/20
07:18
HALO

Halozyme

$19.07 /

-0.58 (-2.95%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sorrento Therapeutics to present clinical trial data for resiniferatoxin » 07:18
01/27/20
01/27
07:18
01/27/20
07:18
SRNE

Sorrento Therapeutics

$4.29 /

+0.105 (+2.51%)

Sorrento Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Target 12% pullback 'key buying opportunity,' says JPMorgan » 07:16
01/27/20
01/27
07:16
01/27/20
07:16
TGT

Target

$114.31 /

-1.23 (-1.06%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
RedHill Biopharma on track to launch Talicia in the U.S. in 1Q20 » 07:15
01/27/20
01/27
07:15
01/27/20
07:15
RDHL

RedHill Biopharma

$5.96 /

-0.045 (-0.75%)

RedHill Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Northland downgrades SolarEdge on expectation for slowing growth » 07:15
01/27/20
01/27
07:15
01/27/20
07:15
SEDG

SolarEdge

$110.13 /

+1.39 (+1.28%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Update: Safe-have currencies rose » 07:15
01/27/20
01/27
07:15
01/27/20
07:15

FX Update: Safe-have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Enthusiast Gaming graduates to the Toronto Stock Exchange » 07:14
01/27/20
01/27
07:14
01/27/20
07:14
ENGMF

Enthusiast Gaming

$0.00 /

+ (+0.00%)

Enthusiast Gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Vivint Smart Home initiated with an Overweight at JPMorgan » 07:13
01/27/20
01/27
07:13
01/27/20
07:13
VVNT

Vivint Smart Home

$11.73 /

+0.01 (+0.09%)

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
5G should drive modest return to Apple iPhone revenue growth, says Credit Suisse » 07:13
01/27/20
01/27
07:13
01/27/20
07:13
AAPL

Apple

$318.25 /

-1.02 (-0.32%)

Ahead of Apple's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Mattel initiated with an Overweight at JPMorgan » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
MAT

Mattel

$14.27 /

-0.17 (-1.18%)

JPMorgan analyst Tami…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Kennedy Wilson initiated with a Neutral at BofA » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
KW

Kennedy Wilson

$22.16 /

-0.32 (-1.42%)

BofA analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Hasbro initiated with a Neutral at JPMorgan » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
HAS

Hasbro

$104.71 /

-0.71 (-0.67%)

JPMorgan analyst Tami…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Anavex achieves enrollment target for ANAVEX 2-73 Phase 2 PDD trial » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
AVXL

Anavex

$2.92 /

-0.08 (-2.67%)

Anavex Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Synchrony price target lowered to $37 from $43 at BMO Capital » 07:11
01/27/20
01/27
07:11
01/27/20
07:11
SYF

Synchrony

$32.63 /

-3.56 (-9.84%)

BMO Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rexnord sees annual increases in common dividend amount » 07:09
01/27/20
01/27
07:09
01/27/20
07:09
RXN

Rexnord

$32.26 /

-0.42 (-1.29%)

Rexnord announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
NuCana announces first patients dosed in Phase III study of Acelarin » 07:09
01/27/20
01/27
07:09
01/27/20
07:09
NCNA

NuCana

$5.11 /

-0.025 (-0.49%)

NuCana announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rexnord expands share repurchase authorization to $300M » 07:08
01/27/20
01/27
07:08
01/27/20
07:08
RXN

Rexnord

$32.26 /

-0.42 (-1.29%)

The Rexnord board…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
EyePoint, Ocumension sign exclusive license agreement for DEXYCU » 07:07
01/27/20
01/27
07:07
01/27/20
07:07
EYPT

EyePoint

$1.93 /

-0.06 (-3.02%)

EyePoint Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Kraft Heinz CEO wants to take fewer, but bigger bets on new products, WSJ says » 07:07
01/27/20
01/27
07:07
01/27/20
07:07
KHC

Kraft Heinz

$30.41 /

-0.29 (-0.94%)

Kraft Heinz CEO Miguel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Johnson & Johnson price target raised to $170 from $163 at Credit Suisse » 07:07
01/27/20
01/27
07:07
01/27/20
07:07
JNJ

Johnson & Johnson

$148.32 /

-0.27 (-0.18%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.